According to Prelude Therapeutics's latest financial reports the company's current earnings (TTM) are -ยฃ0.11 B. In 2023 the company made an earning of -ยฃ0.11 B a decrease over its 2022 earnings that were of -ยฃ94.14 M.The earnings displayed on this page is the company's Pretax Income.